I-RETALRETRAL RENAL CLER Carcinoma Pathology Izindleko

Ukwelashwa kweRenal Cell Carcinoma: I-Pathology, ibala, kanye nezindleko ezicatshangelwe i-pathology, izindlela zokwelashwa, kanye nezindleko ezihambisana ne-Renal Carcinoma (RCC) zibalulekile ezigulini nasemindenini yazo. Lo mhlahlandlela ophelele uhlinzeka ngesibukezo esinemininingwane ye-RCC, egxile kwizici zayo ze-pathological, izindlela ezahlukahlukene zokwelashwa, nezici ezibandakanyekayo.

Ukuqonda i-Renal Cell Carcinoma (RCC)

I-Renal Cell Carcinoma (I-RETALRETRAL RENAL CLER Carcinoma Pathology Izindleko) Uhlobo lomdlavuza wezinso ovela ku-lining of amashubhu kazinso. Kubandisa iningi lomdlavuza wezinso. Indlela yokuqonda kanye nokwelashwa kuncike kakhulu esigabeni somdlavuza, ibanga laso, kanye nokuba khona kwama-metastase. Ukuhlolwa kwe-Pathological kwesibonelo sezicubu (i-biopsy) kubalulekile ekutholweni okunembile kanye nokuzihlaziya.

Izici ze-pathological ze-rcc

I-Pathologists ihlaziya amasampula wezicubu ukuthola uhlobo oluthile lwe-RCC, ibanga layo (elibonisa ukuthi amangqamuzana omdlavuza avela ngaphansi kwesibonakhulu), nesigaba sawo (esibonisa ukuthi umdlavuza wawo (okhombisa ukuthi umdlavuza wawo usakazeke kangakanani). Ama-RCC ​​ama-subtypes ajwayelekile afaka phakathi iseli elicwengekile, i-papillary, i-chromophobe, kanye nokuqoqa ama-carcinomas, ngalinye linezici ezihlukile ze-microscopic. Ukutholwa okuthile kwe-pathological kuthinta kakhulu I-RETALRETRAL RENAL CLER Carcinoma Pathology Izindleko. Ngokwesibonelo, ama-tumors aphezulu aphezulu avame ukudinga amasu wokulashwa anolaka onolaka, okunomthelela ophelele khokhisa.

Izindlela zokwelashwa ze-Renal Cell Carcinoma

Le khasi ukwelapha Isu le-RCC liyahlukahluka ngokuya ngesigaba nohlobo lomdlavuza. Izinketho zokwelashwa zifaka:

Indawo kadokotela

Ukususwa Kokuhlinzwa Kwezinso Ezithintekile (okuyingxenye noma i-Nephrectomy) kuyindlela ejwayelekile yokwelashwa okuvamile kwe-RCC yasendaweni. Ubungako bokuhlinzwa buxhomeke kusayizi nendawo yendawo kanye nendawo.

Ukwelashwa okuhlosiwe

Izindlela zokwelapha ezihlosiwe zisebenzisa izidakamizwa ezibhekise ngqo amaseli omdlavuza, ukunciphisa ukulimala kwamaseli anempilo. Izibonelo zifaka phakathi ama-tyrosine kinase inhibitors (TKIS) njenge-sunitinib ne-pazopanib, kanye ne-mtor inhibitors njenge-EverLimus. Lezi zindlela zokwelapha zivame ukusetshenziselwa i-RCC ethuthukile noma ye-metastatic. Ukusebenza kahle kanye nemiphumela emibi kuyahlukahluka ngokuya ngezinto ezithile neziguli ngazinye.

I-ImmunoSatherapy

I-ImmunoSatherapy ihlanganisa amasosha omzimba wokulwa nokulwa namaseli womdlavuza. I-Imgve Phezulu inhibitors, njengeNivolumab ne-Ipilimamab, zisetshenziselwa kakhulu i-RCC ethuthukisiwe. Lezi zindlela zokwelapha zivuselela amasosha omzimba aqaphele futhi ahlasele amaseli womdlavuza.

Ukwelashwa kwemisebe

Ukwelashwa kwemisebe kungahle kusetshenziselwe ukuncipha kwamathumbu noma ukunciphisa izimpawu ezimweni ezithile. Kuvame ukusetshenziswa ngokubambisana nezinye ukwelapha izindlela.

Chemotherapy

I-Chemotherapy ayisetshenziswa kaningi njengomugqa wokuqala ukwelapha Nge-RCC kepha kungabhekwa kwezinye izimo.

Ukucatshangelwa kwezindleko zokwelashwa kwe-RCC

Le khasi khokhisa iwa- ukwelapha I-RCC ingahlukahluka ngokuya ngezinto ezahlukahlukene, kufaka phakathi: Isigaba somdlavuza: Umdlavuza we-Advanced-Stage ngokuvamile adinga ukwelashwa okubanzi okuningana nokubizayo. Ukulashwa Ngokwelashwa: Izindlela zokwelapha ezihlosiwe kanye nama-acmUNnoSapies zivame ukubiza kakhulu kunokuhlinzwa. Ubude bokwelashwa: isikhathi se ukwelapha kuthinta okuphelele khokhisa. Isibhedlela kanye nezimali zodokotela: Izindleko zingahluka kakhulu ngokuya ngendawo nomhlinzeki wezokunakekelwa kwempilo. Izindleko zokwelapha: The khokhisa yemithi, kufaka phakathi izindlela zokwelapha ezihlosiwe kanye nama-accunotherapies, angaba yinto enkulu.

Uhlobo lokwelashwa	Ibanga elilinganiswayo lezezimali (i-USD)	Amanothi
Ukuhlinzwa (Nephrectomy)	$ 30,000 - $ 100,000	Izindleko ziyehluka kakhulu ngokusekelwe esibhedlela nodokotela ohlinzayo.
Ukwelashwa okuhlosiwe (ngonyaka)	$ 100,000 - $ 200,000	Izindleko zincike kwisidakamizwa esithize kanye nomthamo.
I-ImmunoSatherapy (ngonyaka)	$ 150,000 - $ 300,000	Izindleko zincike kwisidakamizwa esithize kanye nomthamo.

Ukuzikhulula: Amabanga wezindleko alinganiselwa futhi angahluka kakhulu. Thintana nomhlinzeki wakho wezokunakekelwa kwempilo ngemininingwane yezindleko ezenzelwe wena.

Izinsizakusebenza kanye neminye imininingwane

Ngemininingwane eningiliziwe ye-Renal Cell Carcinoma, sicela uthintane nodokotela wakho noma ubheke izinhlangano ezihlonishwayo njengeNational Cancer Institute (https:/www.cancer.gov/) kanye nomphakathi we-American Cancer Society (https:/www.cancer.org/). Ukunakekelwa komdlavuza okwenziwe umuntu eChina, cabanga I-Shandong Baafa Cancer Research Institute.Remember, ukutholwa kusenesikhathi nokushesha ukwelapha zibalulekile ekuthuthukiseni imiphumela e-RCC. Lolu lwazi lwenzelwe izinjongo zokufundisa futhi akufanele lubhekwe njengeluleke lwezokwelapha. Hlala uthintana nochwepheshe wezokunakekelwa kwempilo yokuxilongwa kanye ukwelapha Ukuhlela maqondana I-renal cell carcinoma pathology ibiza.